Vishwakarma
Chandan K. Vishwakarma, Hazaribagh IN
Patent application number | Description | Published |
---|---|---|
20150095289 | ARCHIVAL MANAGEMENT OF DATABASE LOGS - A method for preventing suspension of transactions in a database computing system by monitoring active database logs of the database computing system is provided. The method comprises switching archive units of the database computing system due to full database log condition occurring during system operations of the database computing system. The method further comprises maintaining a database log history table, wherein the database log history table captures a threshold count of the active database logs generated by system threads of the database computing system. The method further comprises defining a temporary location for archiving the active database logs based on the switched archive units of the database computing system, and the maintained threadhold count of active database logs in the database log history table due to full database log condition occurring during system operations of the database computing system. | 04-02-2015 |
Devendra Vishwakarma, Indore IN
Patent application number | Description | Published |
---|---|---|
20130006903 | SYSTEM AND METHOD FOR PREDICTIVE ANALYTICS IN AN ELECTRICAL GRID NETWORK - Systems and methods for performing predictive analytics in an electrical grid network are disclosed. In one example of the disclosed technology, a method comprises aggregating a plurality of events from an electrical grid network, analyzing the plurality of events to recognize at least one event pattern, serializing at least one of the event patterns in a database, and predicting a future event pattern based on a correlation of the plurality of event patterns. | 01-03-2013 |
Harishankar Prahladkumar Vishwakarma, Mumbai IN
Lolaknath Santosh Vishwakarma, Tamilnadu IN
Patent application number | Description | Published |
---|---|---|
20100329998 | NOVEL HETEROCYCLES - Described are novel heterocyclic compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are useful in the treatment of immunological diseases, inflammation, pain disorder, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; atherosclerosis; cancer; cachexia; ischemic-induced cell damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; ARDS; psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; asthma; COPD; bone resorption diseases; multiple sclerosis; sepsis; septic shock; toxic shock syndrome and fever. More particularly these compounds are useful as PDE4 inhibitors and are useful for treating PDE4 mediated diseases. | 12-30-2010 |
Pawan Vishwakarma, Pune IN
Patent application number | Description | Published |
---|---|---|
20110001026 | Metal stud bracket - A bracket for securing an electrical box to a support comprising a base, a first flange extending downwardly from a first portion of the base, a second flange extending downwardly from a second portion of the base wherein the base is positioned between the first and second flanges, a first tooth positioned on the first flange and extending inwardly toward the second flange, and a second tooth positioned on the first flange adjacent to the first tooth and extending inwardly toward the second flange. | 01-06-2011 |
Ram Vishwakarma, Jammu IN
Patent application number | Description | Published |
---|---|---|
20120108627 | IMIDAZO [4,5-C]QUINOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF TUMORS AND/OR INFLAMMATION - The present invention provides the compounds of formula (I): | 05-03-2012 |
20120245183 | MACROCYCLIC LACTONE DERIVATIVES FOR THE TREATMENT OF CANCER - The present invention provides compounds represented by formula (1): wherein, R | 09-27-2012 |
Ram Vishwakarma, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090076094 | NOVEL ANTIBACTERIAL COMPOUNDS - This invention relates to a novel purified compound PM181104, of formula: | 03-19-2009 |
Ram A. Vishwakarma, Jammu IN
Patent application number | Description | Published |
---|---|---|
20160052915 | ROHITUKINE ANALOGS AS CYCLIN-DEPENDENT KINASE INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF - The present invention relates to the rohitukine (5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-4H-chromen-4-ones) analogs of formula A and pharmaceutically acceptable salts thereof. In addition, the invention relates to pharmaceutically acceptable compositions comprising at least one such compound, and methods of using the compounds for treating or preventing various proliferative disorders such as melanoma, leukemia, breast cancer and prostate cancer etc. [insert Formula A here] wherein, n=0 or 1, when n=1, the dotted line indicates the double bond. | 02-25-2016 |
Ram Asrey Vishwakarma, Jammu & Kashmir IN
Patent application number | Description | Published |
---|---|---|
20110009396 | TRICYCLIC COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - The present invention provides compounds represented by formula 1: | 01-13-2011 |
Ram Asrey Vishwakarma, Jammu IN
Patent application number | Description | Published |
---|---|---|
20140045832 | Insulin-Like Growth Factor-1 Receptor Inhibitors - The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating Insulin-Like-Growth Factor I Receptor and Insulin Receptor. The compounds of the instant invention possess a core structure that comprises a sulfonyl indole moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds. | 02-13-2014 |
20150051173 | BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF P13K- a AND/OR B - Compounds with unique liphagane meroterpenoid scaffold having boronic acid functionality in the skeleton are described (formula 1) together with pharmacological potential of these compounds as anticancer agents. A method of preparation and inhibiting the activity of phosphoinositide-3-kinase (PI3K-alpha and beta) has been presented. In particular, the invention describes a method of inhibiting PI3K isoforms, wherein the compounds are novel structures based on liphagane scaffold with unique boronic acid functionality. The methods and uses thereof are described herein this invention. | 02-19-2015 |
20160046611 | NOVEL CHROMONE ALKALOID DYSOLINE FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISORDERS - The present invention relates to novel chromone alkaloid of formula 1 isolated from the plant | 02-18-2016 |
Ritesh Vishwakarma, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090097388 | Method and apparatus for co-location of two radio frequency devices - A method for avoiding signal interference between a first RF device and a second RF device is provided. The first and second RF devices are co-located and the first RF device is configured to operate within a semi-stationary range of a frequency band. The second RF device is configured to operate by changing channels within the frequency band. The method initiates with a communication interface being provided between the first RF device and the second RF device. Then, the second RF device receives the semi-stationary range and a mode for the first RF device through the communication interface. Next, the second RF device is adapted to avoid the semi-stationary range of the frequency band of the first RF device when the mode of the first RF device is in an active mode. An apparatus where two RF devices are co-located without causing interference for each other is also provided. | 04-16-2009 |
20100197234 | Method and Apparatus for Co-Location of Two Radio Frequency Devices - A method for avoiding signal interference between a first RF device and a second RF device is provided. The first and second RF devices are co-located and the first RF device is configured to operate within a semi-stationary range of a frequency band. The second RF device is configured to operate by changing channels within the frequency band. The method initiates with a communication interface being provided between the first RF device and the second RF device. Then, the second RF device receives the semi-stationary range and a mode for the first RF device through the communication interface. Next, the second RF device is adapted to avoid the semi-stationary range of the frequency band of the first RF device when the mode of the first RF device is in an active mode. An apparatus where two RF devices are co-located without causing interference for each other is also provided. | 08-05-2010 |
20120058731 | Method and Apparatus for Co-Location of Two Radio Frequency Devices - A method for avoiding signal interference between a first RF device and a second RF device is provided. The first and second RF devices are co-located and the first RF device is configured to operate in a first frequency range. The second RF device is configured to operate in a second frequency range, where the first frequency range overlaps, at least in part, the first frequency range. The method initiates with a communication interface being provided between the first RF device and the second RF device. Then, the second RF device is configured to avoid RF signal collisions with the first RF device when the first RF device is active. An apparatus where two RF devices are co-located without causing interference for each other is also provided. | 03-08-2012 |
20120282861 | Method and Apparatus for Co-Location of Two Radio Frequency Devices - A method for avoiding signal interference between a first RF circuit and a second RF circuit is provided. The first and second RF circuits are co-located and the first RF circuit is configured to operate in a first frequency range. The second RF circuit is configured to operate in a second frequency range, where the first frequency range overlaps, at least in part, the first frequency range. The method initiates with a controller that is coupled to the first RF circuit and the second RF circuit. Then, the second RF circuit is configured to avoid RF signal collisions with the first RF circuit. An apparatus where two RF devices are co-located without causing interference for each other is also provided. | 11-08-2012 |
20130273949 | Method and Apparatus for Co-location of Two Radio Frequency Devices - A method for avoiding signal interference between a first RF circuit and a second RF circuit is provided. The first and second RF circuits are co-located and the first RF circuit is configured to operate in a first frequency range. The second RF circuit is configured to operate in a second frequency range, where the first frequency range overlaps, at least in part, the first frequency range. The method initiates with a controller that is coupled to the first RF circuit and the second RF circuit. Then, the second RF circuit is configured to avoid RF signal collisions with the first RF circuit. An apparatus where two RF devices are co-located without causing interference for each other is also provided. | 10-17-2013 |
Sanjay Vishwakarma, Kanpur IN
Patent application number | Description | Published |
---|---|---|
20140348328 | SIGNAL QUALITY ESTIMATION AND CONTROL - Several circuits and methods implemented to perform signal quality estimation and control are disclosed. In an embodiment, a method of signal quality estimation includes generating a demodulated signal associated with a radio signal. Information associated with a quality of the demodulated signal is accessed. Further, a value of radio frequency signal-to-noise ratio (RF-SNR) for the radio signal based on the information is estimated. Estimating the value of RF-SNR facilitates in signal quality estimation of the radio signal and control of the demodulated signal. | 11-27-2014 |
Santosh Vishwakarma, Chennai IN
Patent application number | Description | Published |
---|---|---|
20130172350 | PYRIMIDINE COMPOUNDS AND THEIR USES - Pyrimidine compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof, are useful are useful as PDE4 inhibitors and are useful for treating PDE4 mediated diseases and in the treatment of immunological diseases, inflammation, pain disorder, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; atherosclerosis; cancer; cachexia; ischemic-induced cell damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; ARDS; psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; asthma; COPD; bone resorption diseases; multiple sclerosis; sepsis; septic shock; toxic shock syndrome and fever. | 07-04-2013 |
Santosh Vishwakarma, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20100087484 | AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS - The present invention relates to novel aminoalkoxy arylsulfonamide compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. These compounds are useful in the treatment of various disorders that are related to 5-HT | 04-08-2010 |
20100168168 | Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands - The present invention provides aminoaryl sulphonamide derivatives of formula (I), useful in the treatment of a CNS disorder related to or affected by the 5-HT | 07-01-2010 |
Santosh Lolaknath Vishwakarma, Chennai IN
Patent application number | Description | Published |
---|---|---|
20110269753 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS - Compounds of the formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, N-oxides, metabolites and prodrugs thereof. These compounds are phosphodiesterase type 4 (PDE4) inhibitors. They are useful in the treatment of a variety of allergic or inflammatory diseases including asthma, COPD, chronic bronchitis, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, psoriasis, rheumatoid arthritis, ulcerative colitis, Crohn's disease, uveitis, NASH and lupus. | 11-03-2011 |